In the News

51 News Items found
Dr. Alexander Drilon
The FDA has approved the targeted drug repotrectinib for patients 12 and older with tumors that carry gene changes called NTRK fusions. The trial that resulted in the approval was led by MSK investigators.
coffee cup surrounded by beans
Ask the Expert
Recent studies have raised the possibility that coffee might protect against colorectal cancer. MSK surgeon Garrett Nash advises against jumping to conclusions.
Two doctors looking at a patient
Q&A
MSK radiation therapy experts set the record straight about the safety of this effective treatment.
Table with Thanksgiving dinner
Learn how to make guests with cancer feel welcome and included at the table this holiday season.
Photo of an array of high-protein foods, including meat, cheese, milk, and nuts.
Support
Learn how to eat right and stay at a healthy weight by following these tips from MSK experts on diet and nutrition.
MSK radiation oncologist Nancy Lee
In the Clinic
Learn how HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects, sometimes without surgery.
A man in his 70s (prostate cancer patient) smiling for camera
A new technology shows great promise for imaging and treating advanced forms of prostate cancer.
Man in his 70s (prostate cancer patient) smiling for camera
A new treatment that selectively seeks out prostate cancer cells shows great promise for treating advanced forms of the disease.
Dermatologist Ashfaq Marghoob
Feature
5 Surprising Facts about Melanoma
Expand your knowledge of melanoma with these surprising facts.
An MSK patient gets a vaccination from a healthcare provider
RSV is a respiratory disease that spreads in the fall and winter months. Learn about the RSV vaccines, which are approved for people ages 50 and older.